The World of Health & Medicine News

US to cut health aid to Zambia over ‘systemic theft’

US to cut health aid to Zambia over ‘systemic theft’

The United States said it would cut $50 million in annual aid to Zambia’s health sector because the government had failed to stop “systemic theft” of donated medicines and medical supplies.

U.S. President Donald Trump’s administration is finalising a broader review of its foreign aid, but the cut for Zambia is “wholly separate from that process,” U.S. ambassador to Zambia Michael Gonzales said in a statement.

“I am disappointed to share publicly today that since 2021 we have uncovered systemic theft of  life-saving medicines and other products  that were intended for free for the Zambian public,” Gonzales said, adding medicines stolen included antiretroviral drugs used to treat HIV.

Zambia’s health ministry responded in a statement acknowledging the U.S. ambassador’s concerns and said recurrent theft of medicines was a “persistent challenge” dating back to before 2021.

After he was alerted to the issue Zambian President Hakainde Hichilema commissioned an independent forensic audit of the entire medicines supply chain, the ministry said.

A number of officials found to have been involved had been removed from office or suspended, while others were arrested and are set to appear in court.

“We want to assure the public that Zambia currently maintains sufficient stocks of essential medicines, including antiretroviral, antimalarial, and other critical drugs, with no immediate risk of shortages,” Zambia’s health ministry said.

Gonzales said he had recommended to Washington that the U.S. continue to procure and deliver lifesaving medicines and medical supplies to Zambia until January 2026 to provide time for the government to develop a transition plan.

After January, the U.S. will still offer technical and logistics assistance to support humanitarian activities and prevent drug resistance and disease transmission, he said.

spot_img

Explore more

spot_img

EU drugs regulator confirms suicidal thoughts as side effect of hair...

EU drugs regulator confirms suicidal thoughts as side effect of hair loss drug The European drugs regulator said on Thursday its safety panel has confirmed...

US FDA centers to deploy AI internally, following experimental run

US FDA centers to deploy AI internally, following experimental run The U.S. Food and Drug Administration said on Thursday all its centers will deploy artificial...

Sierra Leone’s mpox cases fuel African outbreak, health body says

Sierra Leone's mpox cases fuel African outbreak, health body says Sierra Leone accounted for half of Africa's confirmed mpox cases this week, the continent's main...

US FDA permits use of three natural-source colors in food items

US FDA permits use of three natural-source colors in food items The U.S. Food and Drug Administration said on Friday that it had granted permissions...

The Alarming Global Omega-3 Shortage: How Climate Change Is Making It...

The Alarming Global Omega-3 Shortage: How Climate Change Is Making It Worse A perfect storm threatens the global supply of omega-3 fatty acids, and the...

Novo Nordisk latest drugmaker to drop gender goals in US

Novo Nordisk latest drugmaker to drop gender goals in US Obesity drugmaker Novo Nordisk said on Wednesday it would drop gender representation requirements for senior...

US FDA approves Verastem’s ovarian cancer therapy

US FDA approves Verastem's ovarian cancer therapy  The U.S. Food and Drug Administration has approved Verastem's (VSTM.O), opens new tab combination therapy for patients with a rare...

US FDA approves first at-home test for cervical cancer screening

US FDA approves first at-home test for cervical cancer screening The U.S. Food and Drug Administration has approved the first at-home test for cervical cancer...